no evidence of acquired resistance to 4-hydroperoxycyclophosphamide and cisplatin after clinical treatment with the same drug was found in samples from ovarian cancer and non-hodgkin lymphoma , but there was a definite trend in germ cell testicular tumors to lower sensitivity to cisplatin in previously treated patients .
C0024305
non-hodgkin lymphoma
C0008838
cisplatin